Dr. Agarwal’s Health Care Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Market
CMP Rs 479.25 (9 Oct 2026). 52W range Rs 401.00 to Rs 568.00. PE 80.51. 2027 base Rs 575, bull Rs 599.
Quick Answer
Dr. Agarwal’s Health Care share price prediction 2027 centres on a conservative case of Rs 551, a base case of Rs 575 and a bull case of Rs 599, against a current price of Rs 479.25. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 20.0% upside from today’s price. The daily technical setup reads bearish.
The Dr. Agarwal’s Health Care share price forecast comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 479.25 on NSE as of 9 October 2026, 15.6% below its 52-week high of Rs 568.00, after the company reported net profit of Rs 168.14 crore for FY26.
This Dr. Agarwal’s Health Care stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Dr. Agarwal’s Health Care Share Price Today and Key Data
The Dr. Agarwal’s Health Care share price today is Rs 479.25 on NSE, up 1.75% on the day. The market capitalisation stands at Rs 14,907 crore. Over the past year the price has fallen 4.8% from Rs 503.65. Every Dr. Agarwal’s Health Care stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Dr. Agarwal’s Health Care (AGARWALEYE) |
| Current Price | Rs 479.25 |
| 52-Week High | Rs 568.00 (16 October 2025) |
| 52-Week Low | Rs 401.00 (30 March 2026) |
| Market Cap | Rs 14,907 crore |
| PE Ratio | 80.51 |
| Industry PE | 62.79 |
| PB Ratio | 7.36 |
| EPS (TTM) | Rs 5.84 |
| Return on Equity | 6.58% |
| Debt to Equity | 0.53 |
| Dividend Yield | 0.00% |
| Book Value per Share | Rs 63.88 |
What Is the Dr. Agarwal’s Health Care Share Price Prediction for 2027?
The Dr. Agarwal’s Health Care share price prediction for 2027 is a conservative case of Rs 551, a base case of Rs 575 and a bull case of Rs 599. Against Rs 479.25, these imply 15.0% upside, 20.0% upside and 25.0% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (50.4%) and 4-year CAGR (22.9%) (capped at 15%) | Rs 6.72 (+15.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 551 | +15.0% |
| Base Case | Average of the two (capped at 20%) | Rs 7.01 (+20.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 575 | +20.0% |
| Bull Case | Higher of the two (capped at 25%) | Rs 7.30 (+25.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 599 | +25.0% |
Each target takes today’s price of Rs 479.25 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Dr. Agarwal’s Health Care target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Dr. Agarwal’s Health Care Share Price Forecast: What Has to Go Right by 2027
Each Dr. Agarwal’s Health Care target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Dr. Agarwal’s Health Care Share Price Target: Rs 551
Reaching Rs 551 needs EPS to rise 15.0% to Rs 6.72 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 22.9%.
Base Case for the Dr. Agarwal’s Health Care Share Price Target: Rs 575
Reaching Rs 575 needs EPS to rise 20.0% to Rs 7.01, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 44.6% in Q1 FY27 is at or above that pace, which supports the target.
Bull Case for the Dr. Agarwal’s Health Care Share Price Target: Rs 599
Reaching Rs 599 needs EPS to rise 25.0% to Rs 7.30 with the PE multiple held at today’s level. That is above the 52-week high of Rs 568.00, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 484.12 (200-day EMA) would be the first technical confirmation.
Dr. Agarwal’s Health Care Financial Performance: Revenue, Profit and Margins
Dr. Agarwal’s Health Care earned net profit of Rs 168.14 crore on revenue of Rs 2,124.52 crore in FY26, with profit up 52.4% and revenue up 20.9% compared with FY25. Diluted EPS was Rs 4.18 against Rs 2.78 a year earlier, and that earnings base anchors the Dr. Agarwal’s Health Care share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 713.78 | 43.16 | 1.83 | 29.22% | 6.05% |
| FY23 | 1,031.49 | 103.23 | 4.00 | 28.33% | 10.01% |
| FY24 | 1,376.45 | 95.05 | 3.13 | 29.02% | 6.91% |
| FY25 | 1,757.02 | 110.34 | 2.78 | 29.56% | 6.28% |
| FY26 | 2,124.52 | 168.14 | 4.18 | 29.95% | 7.91% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 620.43 crore against Rs 500.81 crore a year earlier (+23.9%), and the bottom line was a net profit of Rs 55.02 crore against a net profit of Rs 38.06 crore (+44.6%). Operating margin was 28.80% versus 28.98% in the year-ago quarter. Cash flow from operations was Rs 518.99 crore in FY26 against Rs 357.13 crore in FY25. Together these figures set the earnings base for the Dr. Agarwal’s Health Care share price prediction.
Check the Univest Screener for live Dr. Agarwal’s Health Care fundamentals
Is Dr. Agarwal’s Health Care Overvalued or Undervalued Right Now?
Dr. Agarwal’s Health Care trades at a PE of 80.51 against an industry PE of 62.79, which places the stock at a 28.2% premium to the industry average. The price-to-book ratio is 7.36 on a book value of Rs 63.88 per share. Return on equity of 6.58% means the company earns Rs 6.58 of profit for every Rs 100 of shareholder equity.
Debt to equity is 0.53, so borrowings equal about 53% of shareholder equity. No dividend was declared for FY26. This valuation context frames the Dr. Agarwal’s Health Care stock price prediction for 2027 without relying on any outside forecast.
Dr. Agarwal’s Health Care Stock Analysis: Technical Outlook
Dr. Agarwal’s Health Care stock trades below its 50-day SMA of Rs 503.27 and below its 200-day EMA of Rs 484.12, and the combined daily indicators read bearish. The 52-week high of Rs 568.00 was set on 16 October 2025, while the 52-week low of Rs 401.00 came on 30 March 2026.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 37.95 | Weak momentum |
| MACD (12,26,9) | -6.78 vs signal -4.64 | Bearish |
| ADX (14) | 59.47 | Established trend |
| Supertrend (10,3) | Price below Rs 523.26 | Bearish |
| 50-day SMA | Rs 503.27 | Price below |
| 200-day EMA | Rs 484.12 | Price below |
The nearest support level sits at Rs 401.00 (52-week low). The nearest resistance level sits at Rs 484.12 (200-day EMA) and Rs 503.27 (50-day SMA). A sustained move above the nearest resistance would support the Dr. Agarwal’s Health Care share price prediction 2027 base case, and this Dr. Agarwal’s Health Care stock analysis uses daily candles only. Chart signals add context to the Dr. Agarwal’s Health Care share price target without changing the earnings maths.
Dr. Agarwal’s Health Care Shareholding Pattern
Promoters hold 32.34% of Dr. Agarwal’s Health Care as of Jun 2026, down from 32.42% in Jun 2025 across the last 5 quarters. FII holding is 57.96% (down from 59.26% in Jun 2025) and DII holding is 7.72% (up from 6.44% in Jun 2025), which puts combined institutional holding at 65.68%. Public shareholders own 1.98%. Shareholding data is one input for any Dr. Agarwal’s Health Care stock forecast. Ownership is a useful cross-check on any Dr. Agarwal’s Health Care share price prediction.
Key Risks to the Dr. Agarwal’s Health Care Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 28.33% to 29.95% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Dr. Agarwal’s Health Care stock forecast. Revenue was up 20.9% in FY26, and slower revenue growth would weigh on the profit path.
Valuation Risk
The PE of 80.51 is 28.2% above the industry PE of 62.79. Every target here holds the multiple constant, so a narrowing of that premium would leave returns below these targets even if earnings grow as assumed.
Size and Liquidity Risk
Market capitalisation stands at Rs 14,907 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Dr. Agarwal’s Health Care stock price target.
Balance Sheet Risk
Debt to equity of 0.53 means borrowings stand at about 53% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Dr. Agarwal’s Health Care share price forecast.
Technical Risk
The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 401.00 (52-week low) would weaken the setup further.
None of these risks are priced into the Dr. Agarwal’s Health Care stock price target, which assumes today’s multiple.
Conclusion
This Dr. Agarwal’s Health Care stock analysis puts the share price target range for 2027 at Rs 551 to Rs 599, with a base case of Rs 575 against Rs 479.25 today. The inputs are a PE of 80.51 that sits at a 28.2% premium to the industry average, EPS growth of 50.4% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Dr. Agarwal’s Health Care live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Dr. Agarwal’s Health Care Share Price Prediction 2027
What is the Dr. Agarwal’s Health Care share price target for 2027?
Ans. The Dr. Agarwal’s Health Care share price forecast for 2027 has a conservative case of Rs 551, a base case of Rs 575 and a bull case of Rs 599. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Dr. Agarwal’s Health Care share price today?
Ans. Dr. Agarwal’s Health Care trades at Rs 479.25 on NSE as of 9 October 2026, up 1.75% on the day. The 52-week range is Rs 401.00 to Rs 568.00.
Is Dr. Agarwal’s Health Care a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 80.51 is at a 28.2% premium to the industry average, EPS grew 50.4% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Dr. Agarwal’s Health Care stock reach Rs 599 in 2027?
Ans. Reaching Rs 599 needs EPS to rise 25.0% from Rs 5.84 with the PE multiple held at today’s level, plus a daily close above Rs 484.12 (200-day EMA). This is a scenario, not a guarantee.
What are the support and resistance levels for Dr. Agarwal’s Health Care?
Ans. The nearest support levels are Rs 401.00 (52-week low), and the nearest resistance levels are Rs 484.12 (200-day EMA) and Rs 503.27 (50-day SMA).
What are the main risks for Dr. Agarwal’s Health Care stock in 2027?
Ans. The main risks to the Dr. Agarwal’s Health Care share price forecast are a fall in operating margin from the 28.33% to 29.95% range seen since FY22, slower revenue growth after FY26 revenue was up 20.9%, and thin trading volumes. Debt to equity of 0.53 adds balance sheet sensitivity.
How is the Dr. Agarwal’s Health Care target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company’s reported FY26 and 4-year EPS growth.
